Adaptive Phage Therapeutics, Inc. Company Profile

18:54 EDT 21st October 2018 | BioPortfolio

News Articles [969 Associated News Articles listed on BioPortfolio]

Turning a phage

(University of California - San Diego) With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in coll...

Adaptive and Sanofi Collaborate to Use Adaptive’s clonoSEQ Assay in Active and Future Isatuximab Multiple Myeloma Trials

SEATTLE–(BUSINESS WIRE)–Adaptive Biotechnologies, the leader in combining Next Generation Sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immu...

CRISPR-Cas3 Platform Developer Locus Biosciences Acquires EpiBiome Phage Technology

Locus Biosciences, a developer of CRISPR-Cas3-engineered precision antibacterial products, has acquired EpiBiome’s high-throughput bacteriophage phage discovery platform for an undisclosed price, in...

Adaptive Phage Therapeutics – Lung Transplant Patient with Antibiotic Resistant Bacterial Infection Successfully Treated with Bacteriophage

Today, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) p...

Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics

The post Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics appeared first on SynBioBeta.

First phage therapy center in the U.S. signals growing acceptance

Phage therapy went out of fashion in the U.S. decades ago. Now a new center at the University of California, San Diego wants to revive it to combat antibiotic-resistant infections.

#jobs #lifescience Paramount Recruitment: Phage Display Scientist – Cambridge – 9 months FTC

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Phage Display Scientist – Cambridge – 9 mo...

Phage therapy draws renewed interest to combat drug-resistant microbes

(Children's National Health System) In the face of growing antibiotic resistance and few antibiotics in the development pipeline, phages are drawing renewed research interest as a potential silver bul...

PubMed Articles [1057 Associated PubMed Articles listed on BioPortfolio]

Sequencing, genome analysis and host range of a novel Ralstonia phage, RsoP1EGY, isolated in Egypt.

A novel Ralstonia phage was isolated from soil in Egypt. It was designated Ralstonia phage RsoP1EGY using our phage identifier naming approach to reflect the phage's bacterial host species, characteri...

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.

Phage therapy is increasingly put forward as a "new" potential tool in the fight against antibiotic resistant infections. During the "Centennial Celebration of Bacteriophage Research" conference in Tb...

Host range and molecular characterization of a lytic Pradovirus-like Ralstonia phage RsoP1IDN isolated from Indonesia.

A lytic Ralstonia solanacearum-infecting phage designated Ralstonia phage RsoP1IDN was isolated from soil in Indonesia. The phage has a linear double-stranded DNA genome of 41,135 bp with 413-bp termi...

Application of a phage in decontaminating Vibrio parahaemolyticus in oysters.

Vibrio parahaemolyticus is a major pathogen that is mainly associated with seafood and is a global concern of food safety. With high prevalence of contamination in food, efficient strategy is needed t...

1st German Phage Symposium-Conference Report.

In Germany, phage research and application can be traced back to the beginning of the 20th century. However, with the triumphal march of antibiotics around the world, the significance of bacteriophage...

Clinical Trials [672 Associated Clinical Trials listed on BioPortfolio]

Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage

This multi-center, outpatient study will extract and evaluate the presence of facial P. acnes bacteria and phage strains using pore strips on up to 400 human subjects.

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.

Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

This study aims to use a type of radiation (adaptive radiotherapy) to deliver curative-intent treatment to patients with non-small cell lung cancer, whose tumors would otherwise be too lar...

Adaptive Cardiac Resynchronization Therapy Study

The purpose of this study is to show that Adaptive CRT is at least as good at optimizing a patient's cardiac resynchronization therapy (CRT) as the current method of using an echocardiogra...

Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial

This study focuses on the validation of the Adaptation Index instrument as a measurement of adaptive behaviors used to reduce symptoms of FI and to describe the use of adaptive behaviors a...

Companies [1341 Associated Companies listed on BioPortfolio]

Adaptive Phage Therapeutics, Inc.

Adaptive Phage Therapeutics, Inc.

Adaptive Corporation

Adaptive Corporation is a leading provider of Business Process Automation and Product Development technology and services. The company helps its customers become market leaders th...

Mercator Therapeutics, Inc.

Mercator Therapeutics is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. Mercator was founded to translat...

Pepscan Therapeutics BV

Mercator Therapeutics is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. Mercator was founded to translate the research of...

More Information about "Adaptive Phage Therapeutics, Inc." on BioPortfolio

We have published hundreds of Adaptive Phage Therapeutics, Inc. news stories on BioPortfolio along with dozens of Adaptive Phage Therapeutics, Inc. Clinical Trials and PubMed Articles about Adaptive Phage Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Adaptive Phage Therapeutics, Inc. Companies in our database. You can also find out about relevant Adaptive Phage Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record